*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem GlobeNewswire
Market data is delayed by at least 15 minutes.
    Chart Options
    Timeframe
    Frequency
    Graphical Display
    Upper Chart
    Lower Chart
    Compare to Index
    Compare to Company(s)
    Set Chart Options

    Market data provided by News provided by